Literature DB >> 18212496

Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients.

Hung-Yuan Chen1, Tze-Wah Kao, Jenq-Wen Huang, Tzong-Shinn Chu, Kwan-Dun Wu.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) and insulin resistance (IR) strongly promote macrovascular complications and endothelial dysfunction. They accelerate the progression of renal dysfunction in chronic kidney disease patients. However, their correlation with residual renal function (RRF) and peritoneal characteristics have never been investigated.
METHODS: The inter-relationships of IR (homeostatic model assessment, HOMA(IR)), serum adiponectin level, body mass index (BMI), highly sensitive C-reactive protein (hs-CRP), RRF, peritoneal solute clearance (Kt/V(urea)) and solute transport rate of 104 chronic peritoneal dialysis (PD) patients were examined.
RESULTS: Patients with (n = 57) and without (n = 47) clinically diagnosed MetS had the same degree of RRF, peritoneal Kt/V(urea), and solute transport rate. Higher HOMA(IR) (p = 0.011), BMI (p = 0.01) and hs-CRP (p = 0.032), as well as lower adiponectin (p = 0.019), were associated with lower peritoneal Kt/V(urea). Serum adiponectin was negatively associated with solute transport rate (p = 0.02). In multiple regression analysis, higher HOMA(IR) (p = 0.005), BMI (p = 0.021) and hs-CRP (p < 0.001) correlated with lower peritoneal Kt/V(urea).
CONCLUSIONS: MetS plays an important role in both macrovascular complications and endothelial dysfunction in chronic PD patients, which correlates with changes in peritoneal solute clearance and solute transport rate but not RRF. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212496     DOI: 10.1159/000113506

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications.

Authors:  Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Chi-Bon Leung; Mei-Shan Cheng; Man-Ching Law; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

2.  Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients.

Authors:  Erhan Tatar; Meltem Sezis Demirci; Fatih Kircelli; Ozkan Gungor; Mehmet Nuri Turan; Ebru Sevinc Ok; Gulay Asci; Mehmet Ozkahya; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

3.  Insulin resistance in patients undergoing peritoneal dialysis: can we improve it? : editorial to: "the effect of HM-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis" by Fa Mee Doh et al.

Authors:  Kelli King-Morris; T Alp Ikizler
Journal:  Cardiovasc Drugs Ther       Date:  2012-12       Impact factor: 3.727

4.  Ketoacid Supplementation Partially Improves Metabolic Parameters in Patients on Peritoneal Dialysis.

Authors:  Jie Dong; Yan-Jun Li; Rong Xu; Talat Alp Ikizler; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2015-09-15       Impact factor: 1.756

5.  The association between body mass index and mortality on peritoneal dialysis: a prospective cohort study.

Authors:  Yong Kyun Kim; Su-Hyun Kim; Hyung Wook Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong-Lim Kim; Yon-Su Kim; Shin-Wook Kang; Nam-Ho Kim; Chul Woo Yang
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

6.  Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.

Authors:  Ana Paula Bernardo; Jose C Oliveira; Olivia Santos; Maria J Carvalho; Antonio Cabrita; Anabela Rodrigues
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-27       Impact factor: 8.237

Review 7.  Protective measures against ultrafiltration failure in peritoneal dialysis patients.

Authors:  Anna Rita Aguirre; Hugo Abensur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients.

Authors:  Jenq-Wen Huang; Chung-Yi Yang; Hon-Yen Wu; Kao-Lang Liu; Chi-Ting Su; Cho-Kai Wu; Jen-Kuang Lee; Chih-Kang Chiang; Hui-Teng Cheng; Yu-Chung Lien; Kuan-Yu Hung
Journal:  Cardiovasc Diabetol       Date:  2013-06-08       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.